Table 2.
Supplemental information related to COVID-19 vaccination uptake.
| N | % | |
|---|---|---|
| Uptake of at least one dose of COVID-19 vaccination in different study site | ||
| Beijing (n = 597) | 103 | 17.3 |
| Shenyang (n = 348) | 5 | 1.4 |
| Tianjin (n = 330) | 11 | 3.3 |
| Nanjing (n = 318) | 5 | 1.6 |
| Hohhot (n = 324) | 11 | 3.4 |
| Nanning (n = 305) | 15 | 4.9 |
| Shenzhen (n = 216) | 7 | 3.2 |
| Guangzhou (n = 302) | 13 | 4.3 |
| All participants (n = 2740) | 170 | 6.2 |
| Number of doses received (among vaccinated participants, n = 170) | ||
| 1 | 74 | 43.5 |
| 2 | 96 | 56.5 |
| Side effects of COVID-19 vaccination | ||
| Muscle pain or joint pain | 15 | 8.8 |
| Fatigue, headache, dizziness or drowsiness | 28 | 16.5 |
| Pain at injection site | 65 | 38.2 |
| Redness, swelling, itching, induration or rash at injection site | 7 | 4.1 |
| Itching in non-vaccinated area | 2 | 1.2 |
| Fever (mild, transient) | 10 | 5.9 |
| Nausea, vomiting or diarrhea | 1 | 0.6 |
| Others | 6 | 3.5 |
| Self-reported having serious side effects of COVID-19 vaccination | ||
| No | 168 | 98.8 |
| Yes | 2 | 1.2 |